Antiphospholipid antibodies linked to future CV events.

The article informs that a new study has found that the presence of antiphospholipid antibodies is associated with an increased risk of future cardiovascular events.It mentions the findings showed that individuals testing positive for certain antiphospholipid antibodies had a significantly higher risk of myocardial infarction, stroke, coronary revascularization, or cardiovascular death.